Atlas Trials

Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer

Clinical trial NCT06147960 · RECRUITING

Trial details

NCT number
NCT06147960
Sponsor
Centre Hospitalier Universitaire de Nīmes
Status
RECRUITING
Study type
OBSERVATIONAL
Cancer of CervixApoptosis
Start date
2024-09-26
Primary completion
2027-05-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.